Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Anti-TNF antibodies, compositions, methods and use for the treatment or prevention of type 1 diabetes

Anti-TNF antibodies, compositions, methods and use for the treatment or prevention of type 1 diabetes

US Patent 10465003 · Granted Nov 5, 2019

Estimated economic value: $91,398,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Safe and effective method of treating psoriatic arthritis with anti-IL23 specifi2025
Anti-TNF antibodies, compositions, and methods for the treatment of active Ankyl2025
Glucagon like peptide 1 (GLP1)-growth differentiation factor 15 (GDF15) fusion p2025
Anti-TNF antibodies, compositions, and methods for the treatment of active ankyl2024
Glucagon like peptide 1 (GLP-1) fusion peptide coupled cyclic peptide tyrosine t2023
Glucagon like peptide 1 (GLP1)-growth differentiation factor 15 (GDF15) fusion p2023
Nucleic acids encoding anti-CD154 antibodies2022
Method for treating pre-type 1 diabetes in a human subject2021
Method for treating pre-type 1 diabetes in a human subject2021
Method for treating pre-type 1 diabetes in a human subject2021
Method for treating pre-type 1 diabetes in a human subject2021
Method for treating pre-type 1 diabetes in a human subject2021